Wound Healing Factor

From Noblood

An autologous platelet-derived formula containing growth factors intended to treat nonhealing wounds. It is provided through hospital-based outpatient facilities as part of comprehensive wound-care programs designed to treat patients with chronic nonhealing wounds. It is usually applied at first in the presence of a physician, with the patient continuing applications at home.

Contents 1 Primary component of origin 2 Percent of component 3 Production 4 Medicinal Value 5 Risks 6 Pharmaceuticals, found in 7 Alternatives 8 Factoids 9 See also

Primary component of origin

Platelets.

Percent of component

Production

Medicinal Value

Risks

Pharmaceuticals, found in

Procuren®. However as of 2002 this product is no longer marketed, autologous platelet gel being the preferred healing agent of this kind.

AutoloGel™ and SafeBlood® are two related but distinct autologous blood-derived preparations that can be prepared at the bedside for immediate application. Both AutoloGel™ and SafeBlood® have been specifically marketed for wound healing.

Alternatives

Regranex® - A genetically engineered platelet-derived growth factor that mimics a protein that occurs naturally in the body.

Factoids

See also

Centers for Medicare and Medicaid Services